Kohno I, Ijiri H, Takusagawa M, Yin D F, Sano S, Ishihara T, Sawanobori T, Komori S, Tamura K
Second Department of Internal Medicine, Yamanashi Medical University, Japan.
Chronobiol Int. 2000 Mar;17(2):209-19. doi: 10.1081/cbi-100101044.
The purpose of the study was to identify differences in the patterns of efficacy and duration of effects of imidapril administered at different times of the day (morning versus evening) in dipper and nondipper hypertensive patients. Twenty patients with untreated hypertension were classified into two groups: dippers (n = 9) and nondippers (n = 11). Imidapril (10 mg) was given at 07:00 or 18:00 for 4 weeks in a crossover fashion. Blood pressure (BP) and heart rate (HR) were monitored before and after morning and evening treatment every 30 min for 48h by ambulatory BP monitoring (ABPM). In dipper hypertension, the mean 48h BP was reduced with both doses. The decrease in the diurnal BP was stronger when the drug was administered in the evening than morning, but without significant difference. In nondipper hypertension, the systolic BP decreased at night with both doses, but the extent of the nocturnal reduction in systolic BP was greater after morning therapy. There were no significant differences in the decrease in BP during the day or night between the morning and evening administrations. When imidapril was administered in the morning, its serum concentration reached a maximum at 16:00, and when the drug was administered in the evening, it reached a maximum at 6:00. In dipper hypertension, the time taken for the blood concentration of imidapril to reach a maximum changed depending on its time of administration, and the time when the maximum antihypertensive effect of the drug appeared was different. In nondipper hypertension, decreases in the BP were confirmed at night regardless of the time of administration; this might be caused by angiotensin converting enzyme (ACE) inhibitors effectively blocking the BP from increasing by activating the parasympathetic nervous system. Therefore, when assessing the effectiveness of antihypertensive agents, factors such as the various patterns of BP before therapy and administration time must be considered.
该研究的目的是确定在勺型和非勺型高血压患者中,一天中不同时间(早晨与晚上)服用咪达普利的疗效模式和作用持续时间的差异。20例未经治疗的高血压患者被分为两组:勺型(n = 9)和非勺型(n = 11)。咪达普利(10 mg)以交叉方式于07:00或18:00给药,持续4周。通过动态血压监测(ABPM)在早晨和晚上治疗前后每30分钟监测48小时的血压(BP)和心率(HR)。在勺型高血压中,两种剂量均使平均48小时血压降低。当药物在晚上给药时,日间血压的下降比早晨更强,但无显著差异。在非勺型高血压中,两种剂量均使夜间收缩压降低,但早晨治疗后夜间收缩压降低的程度更大。早晨和晚上给药之间白天或晚上血压下降无显著差异。当咪达普利在早晨给药时,其血清浓度在16:00达到最大值,当在晚上给药时,在6:00达到最大值。在勺型高血压中,咪达普利血药浓度达到最大值的时间根据给药时间而变化,药物出现最大降压作用的时间也不同。在非勺型高血压中,无论给药时间如何,夜间血压均有下降;这可能是由于血管紧张素转换酶(ACE)抑制剂通过激活副交感神经系统有效阻止血压升高所致。因此,在评估抗高血压药物的有效性时,必须考虑治疗前血压的各种模式和给药时间等因素。